Remdesivir, anti-COVID drug to be available in the country within three weeks

The Drug Regulatory Authority of Pakistan (Drap) said on Monday that Remdesivir, an effective anti-COVID 19 drug, will be available in the country within three weeks. Drap, after registration of the medicine, had allowed two pharmaceutical companies to import this critical drug. The regulator has given licences to 14 manufacturers for producing the medicine at home.

Remdesivir injection is an antiviral which stops the virus from reproducing itself or slows down its ability to do so.

The drug has been approved for use in the United States, Japan, South Korea and the European Union after its clinical trials turned out to be encouraging.

Source: Dawn